Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really? 10/08/2020 Elaine Ruth Fletcher More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
“A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Posts navigation Older postsNewer posts